Document is current
Any future updates will be listed below
-
Authors
Briggs, Logan G. https://orcid.org/0000-0001-6406-5784
Psutka, Sarah P.
Van Ligten, Matthew J.
Beck, Kelsey L.
Sinha, Debarshi
Gill, Vikram S.
Alkhatib, Khalid Y. https://orcid.org/0000-0002-6008-0503
Durant, Adri M.
Bain, Paul A.
Quillen, Jaxon
Dodoo, Christopher
Pierorazio, Phillip M. https://orcid.org/0000-0003-0766-9981
Abdul-Muhsin, Haidar
Tyson, Mark D.
Trinh, Quoc-Dien https://orcid.org/0000-0003-3857-9276
Parke, Sara C. https://orcid.org/0000-0002-2790-5200
- License Information
-
More Information
Article History
Accepted: 20 August 2025
First Online: 22 September 2025
Competing interests
: L.G.B. reports consulting fees from Delfina Inc and Tolmar outside of the submitted work and research funding from the Office of Scholarly Engagement at Harvard Medical School. S.P.P. serves on the advisory board for Immunity Bio Merck and Pfizer, receives research funding from Bladder Cancer Advocacy Network and the National Institute on Aging, consulting fees from CG Oncology and Janssen, serves on the editorial boards for European Urology and Bladder Cancer, and serves on guidelines committees for AUA Upper Tract Urothelial Carcinoma and AUA Practice Guidelines Committee. K.Y.A. serves on the Board of Directors for the Testicular Cancer Awareness Foundation (uncompensated position). P.M.P. serves on the Board of Directors for the Testicular Cancer Awareness Foundation (uncompensated position) and on Testicular Cancer guidelines committees for the AUA and NCCN. Q.D.T. reports consulting fees from Astellas, Bayer, Intuitive Surgical, Janssen, Novartis and Pfizer, and research funding from the American Cancer Society, Pfizer Global Medical Grants (Prostate Cancer Disparities no. 63354905) and a Health Disparity Research Award from the Department of Defense Congressionally Directed Medical Research Program (no. PC220551). All other authors declare no competing interests.
